Collagenous Colitis
6
Pipeline Programs
2
Companies
3
Clinical Trials
3
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
3
3
Early DiscoveryClinical DevelopmentMarket
On Market (3)
Approved therapies currently available
Competitive Landscape
2 companies ranked by most advanced pipeline stage
AstraZenecaCAMBRIDGE, United Kingdom
2 programs2
1
BudesonidePhase 31 trial
BudesonidePhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Dr. Falk PharmaBudesonide
AstraZenecaBudesonide
AstraZenecaBudesonide
Clinical Trials (3)
Total enrollment: 203 patients across 3 trials
Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis
Start: Mar 2007Est. completion: Aug 201192 patients
Phase 3Completed
Long-Term Treatment of Collagenous Colitis With Budesonide
Start: Sep 2004Est. completion: Mar 200636 patients
Phase 3Unknown
Budesonide for Maintenance Treatment of Collagenous Colitis
Start: Jul 2004Est. completion: Mar 200875 patients
Phase 3Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.